A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Ahead of Hillary Clinton's historic clash with Donald Trump, we look at key moments that changed election outcomes.
An ejector seat manufacturer is to be prosecuted over the death of Red Arrows pilot Sean Cunningham at RAF Scampton in November 2011.
Police said the "active shooter", reportedly a lawyer, had since been shot by officers and they were not seeking any other suspects.